Current understanding of Age-related macular degeneration
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the elderly population 50 years of age or older in the developed countries. This review discusses the traditional clinical and histopathological presentation of AMD, epidemiology and genetics component in relat...
Main Author: | Swathi Kanduri |
---|---|
Format: | Article |
Language: | English |
Published: |
International Journal of Retina
2020-09-01
|
Series: | IJRETINA (International Journal of Retina) |
Online Access: | https://www.ijretina.com/index.php/ijretina/article/view/112 |
Similar Items
-
Age-related macular degeneration: current treatments
by: Jean Pierre Hubschman, et al.
Published: (2009-01-01) -
Treatment of age related macular degeneration (AMD) currently and in the past
by: Klaudia Brożyna, et al.
Published: (2018-08-01) -
Treatment of neovascular age-related macular degeneration: Current therapies
by: Albert J Augustin, et al.
Published: (2009-01-01) -
Current and emerging therapies for the treatment of age-related macular degeneration
by: M Vaughn Emerson, et al.
Published: (2008-06-01) -
Age-related macular degeneration
by: Wanjiku Mathenge
Published: (2014-12-01)